A. Craig Lockhart

2.3k total citations
49 papers, 1.0k citations indexed

About

A. Craig Lockhart is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Craig Lockhart has authored 49 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 23 papers in Molecular Biology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Craig Lockhart's work include Gastric Cancer Management and Outcomes (9 papers), Cancer therapeutics and mechanisms (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). A. Craig Lockhart is often cited by papers focused on Gastric Cancer Management and Outcomes (9 papers), Cancer therapeutics and mechanisms (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). A. Craig Lockhart collaborates with scholars based in United States, Japan and France. A. Craig Lockhart's co-authors include Mace L. Rothenberg, Wooin Lee, Richard B. Kim, Jeffrey A. Sosman, David R. Spriggs, Wendy Cooper, Jakob Dupont, Jordan Berlin, Mark W. Dewhirst and Lars Sternås and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

A. Craig Lockhart

48 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Craig Lockhart United States	17	522	477	261	234	102	49	1.0k
David Páez Spain	20	559 1.1×	828 1.7×	292 1.1×	265 1.1×	211 2.1×	75	1.3k
Haitian Quan China	17	492 0.9×	662 1.4×	383 1.5×	137 0.6×	115 1.1×	30	1.3k
Dale R. Shepard United States	17	419 0.8×	478 1.0×	470 1.8×	258 1.1×	115 1.1×	75	1.2k
Teresa Di Desidero Italy	24	421 0.8×	542 1.1×	253 1.0×	200 0.9×	44 0.4×	52	1.1k
Hao‐Xiang Wu China	22	520 1.0×	596 1.2×	289 1.1×	393 1.7×	141 1.4×	38	1.3k
Simone Steinbild Germany	12	353 0.7×	488 1.0×	263 1.0×	147 0.6×	43 0.4×	19	863
Maja J. De Jonge Netherlands	16	471 0.9×	449 0.9×	298 1.1×	114 0.5×	45 0.4×	43	849
Fraser Symmans United States	14	596 1.1×	597 1.3×	317 1.2×	290 1.2×	112 1.1×	21	1.2k
Remy B. Verheijen Netherlands	18	542 1.0×	630 1.3×	794 3.0×	182 0.8×	105 1.0×	50	1.4k
Marlies H.G. Langenberg Netherlands	15	604 1.2×	749 1.6×	417 1.6×	367 1.6×	79 0.8×	34	1.3k

Countries citing papers authored by A. Craig Lockhart

Since Specialization

Citations

This map shows the geographic impact of A. Craig Lockhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Craig Lockhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Craig Lockhart more than expected).

Fields of papers citing papers by A. Craig Lockhart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Craig Lockhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Craig Lockhart. The network helps show where A. Craig Lockhart may publish in the future.

Co-authorship network of co-authors of A. Craig Lockhart

This figure shows the co-authorship network connecting the top 25 collaborators of A. Craig Lockhart. A scholar is included among the top collaborators of A. Craig Lockhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Craig Lockhart. A. Craig Lockhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kawanishi, Natsuko, Yasmine Baca, Joanne Xiu, et al.. (2021). Molecular characterization of pancreatic cancers as seen in the SLUG gene revealing cancer progression.. Journal of Clinical Oncology. 39(3_suppl). 433–433. 1 indexed citations

Sanjeevaiah, Aravind, Rama Suresh, Rutika Mehta, et al.. (2020). P-131 Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma: Interim analysis of a phase II trial. Annals of Oncology. 31. S132–S132. 1 indexed citations

Subbiah, Vivek, Igor Puzanov, Jean‐Yves Blay, et al.. (2020). Pan-Cancer Efficacy of Vemurafenib in BRAF V600-Mutant Non-Melanoma Cancers. Cancer Discovery. 10(5). 657–663. 86 indexed citations

Lockhart, A. Craig, et al.. (2020). Role of Immunotherapy in Advanced Gastroesophageal Cancer. Current Oncology Reports. 22(11). 112–112. 6 indexed citations

Battaglin, Francesca, Joanne Xiu, Yasmine Baca, et al.. (2020). 1952P Comprehensive profiling of MDM2 amplified gastrointestinal (GI) cancers. Annals of Oncology. 31. S1100–S1100. 2 indexed citations

Patel, Chirag, Sanjay Goel, Manish R. Patel, et al.. (2020). Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid Tumors. Clinical Pharmacology in Drug Development. 9(7). 876–888. 7 indexed citations

Park, Haeseong, Tanner M. Johanns, A. Craig Lockhart, et al.. (2019). Abstract CT212: Combining pembrolizumab with locally delivered radiation therapy for the treatment of metastatic esophageal cancer. Cancer Research. 79(13_Supplement). CT212–CT212. 1 indexed citations

Zhou, Xiaofei, A. Craig Lockhart, Siqing Fu, et al.. (2019). Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib in Adult Patients With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Dysfunction. The Journal of Clinical Pharmacology. 59(9). 1204–1215. 3 indexed citations

Zhu, Shoumin, Zheng Chen, Lihong Wang, et al.. (2018). A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers. Clinical Cancer Research. 24(8). 1905–1916. 14 indexed citations

10.

Wang-Bishop, Lihong, Zheng Chen, A. Craig Lockhart, et al.. (2018). Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1. Gastroenterology. 156(3). 662–675.e7. 71 indexed citations

11.

Samson, Pamela, Varun Puri, A. Craig Lockhart, et al.. (2018). Adjuvant chemotherapy for patients with pathologic node-positive esophageal cancer after induction chemotherapy is associated with improved survival. Journal of Thoracic and Cardiovascular Surgery. 156(4). 1725–1735. 24 indexed citations

12.

Shah, Manish A., Takashi Kojima, Peter C. Enzinger, et al.. (2018). Pembrolizumab for patients with previously treated metastatic adenocarcinoma or squamous cell carcinoma of the esophagus: Phase 2 KEYNOTE-180 study.. Journal of Clinical Oncology. 36(15_suppl). 4049–4049. 7 indexed citations

13.

Zhou, Xiaofei, John Nemunaitis, Shubham Pant, et al.. (2017). Effect of alisertib, an investigational aurora a kinase inhibitor on the QTc interval in patients with advanced malignancies. Investigational New Drugs. 36(2). 240–247. 6 indexed citations

14.

Lockhart, A. Craig, Yongjian Liu, Farrokh Dehdashti, et al.. (2015). Phase 1 Evaluation of [64Cu]DOTA-Patritumab to Assess Dosimetry, Apparent Receptor Occupancy, and Safety in Subjects with Advanced Solid Tumors. Molecular Imaging and Biology. 18(3). 446–453. 37 indexed citations

15.

Lockhart, A. Craig, Mace L. Rothenberg, Jakob Dupont, et al.. (2009). Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 28(2). 207–214. 183 indexed citations

16.

Lee, Wooin, et al.. (2009). Novel targets in esophageal and gastric cancer: beyond antiangiogenesis. Expert Opinion on Investigational Drugs. 18(9). 1351–1364. 16 indexed citations

17.

Goff, Laura W., Mace L. Rothenberg, A. Craig Lockhart, et al.. (2008). A Phase I Trial of Irinotecan Alternating With Epirubicin in Patients With Advanced Malignancies. American Journal of Clinical Oncology. 31(5). 413–416. 4 indexed citations

18.

Czito, Brian G., Darrel P. Cohen, Chris R. Kelsey, et al.. (2007). A Phase I Study of UFT/Leucovorin, Carboplatin, and Paclitaxel in Combination With External Beam Radiation Therapy for Advanced Esophageal Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 70(4). 1066–1072. 1 indexed citations

19.

Lockhart, A. Craig, Rod D. Braun, Daohai Yu, et al.. (2003). A clinical model of dermal wound angiogenesis. Wound Repair and Regeneration. 11(4). 306–313. 16 indexed citations

20.

Shan, Siqing, et al.. (2001). The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.. PubMed. 7(8). 2590–6. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact